Aminex Therapeutics is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs). Aminex's novel cancer immunotherapy drug, AMX-513, enables the body's immune system to attack cancer and its ability to spread by modulating myeloid-derived suppressor cells (MDSCs).

Aminex Therapeutics is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs). Aminex's novel cancer immunotherapy drug, AMX-513, en...Show all